ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,018.31
-1.13%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Photocure Asa (0IMT)

  7. Photocure Asa (0IMT) Noticias

0IMT

Photocure Asa (0IMT)

Photocure Asa
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:0IMT
FechaHoraFuenteTítuloSímboloCompañía
09/08/202301:30PR Newswire (US)Photocure ASA: Results for the second quarter and first half of 2023LSE:0IMTPhotocure Asa
06/07/202303:57PR Newswire (US)Photocure Partner Asieris announces completion of enrollment for Hexvix Phase III clinical trial in ChinaLSE:0IMTPhotocure Asa
10/05/202301:18PR Newswire (US)Photocure ASA: Results for the first quarter of 2023LSE:0IMTPhotocure Asa
04/05/202306:48PR Newswire (US)Photocure ASA - Correction: Annual general meeting heldLSE:0IMTPhotocure Asa
03/05/202311:58PR Newswire (US)Photocure ASA - Annual general meeting heldLSE:0IMTPhotocure Asa
03/05/202304:53PR Newswire (US)Photocure ASA: Invitation to presentation of first quarter 2023 financial resultsLSE:0IMTPhotocure Asa
02/05/202310:35PR Newswire (US)Photocure: Nordic registry clinical data and multiple scientific programs at AUA 2023 Congress reinforce the benefits of Blue Light CystoscopyLSE:0IMTPhotocure Asa
12/04/202309:14PR Newswire (US)Photocure ASA: Annual Report 2022LSE:0IMTPhotocure Asa
12/04/202309:14PR Newswire (US)Photocure ASA - Notice of the Annual General Meeting 3 May 2023LSE:0IMTPhotocure Asa
14/03/202302:53PR Newswire (US)Photocure: New data presented at EAU 2023 highlight the effects of blue light cystoscopy in bladder cancerLSE:0IMTPhotocure Asa
23/02/202301:29PR Newswire (US)Photocure ASA: Results for the fourth quarter of 2022LSE:0IMTPhotocure Asa
20/02/202300:43PR Newswire (US)Clinical data presented at ASCO GU demonstrates reduced risk of recurrence in non-muscle invasive bladder cancer with the use of BLCLSE:0IMTPhotocure Asa
03/01/202300:47PR Newswire (US)New study publication reinforces the clinical benefits of Blue Light Cystoscopy in the ASC setting; supports ongoing initiatives to further improve reimbursementLSE:0IMTPhotocure Asa
05/12/202201:08PR Newswire (US)New Evidence: Positive Impact of Blue Light Cystoscopy on Recurrence in Bladder Cancer Presented at the Annual SUO MeetingLSE:0IMTPhotocure Asa
07/11/202201:11PR Newswire (US)Photocure: CMS improves Medicare reimbursement for Blue Light Cystoscopy with Cysview and expands access in the surveillance settingLSE:0IMTPhotocure Asa
02/11/202202:38PR Newswire (US)Photocure ASA: Results for the third quarter of 2022LSE:0IMTPhotocure Asa
04/10/202200:52PR Newswire (US)Data presented at the International Bladder Cancer Network (IBCN) meeting demonstrate a reduction in the risk of recurrence with the use of BLCLSE:0IMTPhotocure Asa
28/09/202201:13PR Newswire (US)Photocure Announces the Commercial Availability of Karl Storz's New Blue Light System in the U.S.LSE:0IMTPhotocure Asa
20/09/202200:54PR Newswire (US)New study demonstrates that tumor removal in the outpatient setting is as good as TURBT under general anesthesiaLSE:0IMTPhotocure Asa
08/09/202200:44PR Newswire (US)Bladder Cancer technology: New KARL STORZ Blue Light Cystoscopy system featured during E-Masterclass in UrologyLSE:0IMTPhotocure Asa
01/09/202201:20PR Newswire (US)Photocure appoints Anders Neijber, MD, PhD as Chief Medical Officer, Global Medical Affairs and Clinical DevelopmentLSE:0IMTPhotocure Asa
10/08/202201:18PR Newswire (US)Photocure ASA: Results for the second quarter of 2022LSE:0IMTPhotocure Asa
09/08/202203:47PR Newswire (US)Photocure Partner Asieris Announces Completion of Patient Enrollment in Cevira Phase III Clinical TrialLSE:0IMTPhotocure Asa
04/08/202208:15PR Newswire (US)Photocure ASA: Invitation to presentation of second quarter and first half year 2022 financial resultsLSE:0IMTPhotocure Asa
05/07/202200:41PR Newswire (US)Photocure Collaborations at EAU Support the Latest Advancements in Bladder Cancer TechnologyLSE:0IMTPhotocure Asa
13/06/202200:50PR Newswire (US)Positive Data from the Danish National Patient Registry presented at the 2022 Nordic Urologisk Forening (NUF) Congress in HelsinkiLSE:0IMTPhotocure Asa
18/05/202200:46PR Newswire (US)Blue Light Cystoscopy continues to make news at AUA 2022LSE:0IMTPhotocure Asa
11/05/202201:18PR Newswire (US)Photocure ASA: Results for the first quarter of 2022LSE:0IMTPhotocure Asa
29/03/202210:14PR Newswire (US)Photocure to Participate in Two Investor Conferences in April: DNB Small & Medium Enterprises and Needham HealthcareLSE:0IMTPhotocure Asa
11/03/202201:59PR Newswire (US)Photocure Partner Asieris announces CDE Approval for Hexvix Clinical Real-World Evidence Study in ChinaLSE:0IMTPhotocure Asa
 Showing the most relevant articles for your search:LSE:0IMT

Su Consulta Reciente

NYSE
MCD
McDonalds
NYSE
DIS
Walt Disney
NYSE
CVX
Chevron
NASDAQ
MSFT
Microsoft
NYSE
KO
Coca Cola
AMEX
SPY
SPDR S&P 500
NYSE
AXP
American Express
FX
EURMXN
Euro vs MXN
USOTC
ADDYY
Adidas (QX)
CCOM
SILVER
SILVER
NYSE
BAC
Bank of America
CCOM
US30
US 30
NYSE
JPM
JP Morgan Chase
USOTC
BASFY
BASF (QX)
USOTC
RHHBY
Roche (QX)
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados